Dr. Debu Tripathy discusses the FDA approval of Enhertu in unresectable or metastatic hormone receptor HR+, HER2-low or -ultralow breast cancer.

A federal judge blocked a new National Institutes of Health policy from going into effect in 22 states that sued the agency, ...

Houston’s largest health care institutions stand to lose tens of millions of dollars under a new National Institutes of ...

Researchers from Rice University and Baylor College of Medicine have developed a new treatment that eliminates advanced-stage ...

Breast cancer cases in men only account for 1% of all breast cancer diagnoses. But, knowing the signs, causes, and treatments remain important.

Exxon Mobil also donated $10 million to MD Anderson Cancer Center a decade ago to launch the cancer prevention program in its inaugural community. The University of Texas MD Anderson Cancer Center ...

leaders in Beaumont are working with The University of Texas MD Anderson Cancer Center to launch Be Well™ Beaumont through a newly announced $10 million gift from ExxonMobil. Community members ...

Rice University chemist and director of the university’s Synthesis X Center Han Xiao and cancer biologist Dihua Yu of The University of Texas MD Anderson Cancer Center have received a three-year, $1.5 ...

Debate over labeling certain cancers as 'benign' or 'premalignant' instead of 'cancer' due to stigma and fear. Experts weigh in on potential impact ...

of the University of Texas MD Anderson Cancer Center in Houston, and colleagues in JAMA Internal Medicine. Patients who received 12-week nicotine replacement therapy or prescription ...

A new nasal delivery method for amifostine could protect healthy tissue during pancreatic cancer radiation therapy, ...